BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18576213)

  • 21. Ophthalmic artery ischemic syndrome associated with neurofibromatosis and moyamoya syndrome.
    Witmer MT; Levy R; Yohay K; Kiss S
    JAMA Ophthalmol; 2013 Apr; 131(4):538-9. PubMed ID: 23430230
    [No Abstract]   [Full Text] [Related]  

  • 22. A Case of Neurofibromatosis Type 1 Complicated with Repeated Intracerebral Hemorrhage due to Quasi-Moyamoya Disease.
    Hayashi K; Morofuji Y; Horie N; Izumo T
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):e109-13. PubMed ID: 25804563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic hypertension followed by insidious stroke in a 12-year-old boy with childhood neurofibromatosis type 1 presenting with renal and cerebral artery vasculopathy.
    Lee ML; Chang TM; Yang RC; Yang AD; Chen M
    Turk J Pediatr; 2019; 61(4):629-634. PubMed ID: 31990487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult-onset Moyamoya disease in a patient with neurofibromatosis type 1.
    Jiménez Caballero PE
    Neurologia; 2016 Mar; 31(2):139-41. PubMed ID: 24801636
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of intra-aortic balloon pump as cerebral protection in a patient with moyamoya disease undergoing coronary artery bypass grafting.
    Kashima I; Inoue Y; Takahashi R
    Interact Cardiovasc Thorac Surg; 2008 May; 7(3):522-3. PubMed ID: 18258651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndrome.
    Yamashita Y; Kusaga A; Koga Y; Nagamitsu S; Matsuishi T
    Pediatr Neurol; 2004 Nov; 31(5):364-6. PubMed ID: 15519121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Moyamoya disease associated with hemoglobin Fairfax and beta-thalassemia.
    Marden FA; Putman CM; Grant JM; Greenberg J
    Pediatr Neurol; 2008 Feb; 38(2):130-2. PubMed ID: 18206795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Athymhormic syndrome caused by bilateral striato-capsular infarction. Moyamoya disease in adults].
    Milandre L; Habib M; Royère ML; Gouirand R; Khalil R
    Rev Neurol (Paris); 1995; 151(6-7):383-7. PubMed ID: 7481401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient.
    Darrigo Júnior LG; Valera ET; Machado Ade A; Santos AC; Scrideli CA; Tone LG
    Sao Paulo Med J; 2011 Mar; 129(2):110-2. PubMed ID: 21603789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurofibromatosis and extensive intracranial arterial occlusive disease (moyamoya disease). Report of a case].
    Gracia CM; Bittencourt PC; Mazer S; Bittencourt PR
    Arq Neuropsiquiatr; 1986 Dec; 44(4):395-400. PubMed ID: 3111450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric moyamoya disease presenting with intracerebral hemorrhage--report of three cases and review of the literature.
    Suyama K; Yoshida K; Takahata H; Toda K; Baba H; Ishikawa Y; Hirose M; Nagata I
    Clin Neurol Neurosurg; 2008 Mar; 110(3):270-5. PubMed ID: 18035479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofibromatosis 1 associated with an intracranial artery abnormality, moyamoya disease and bilateral congenital large hairy pigmented macules.
    Fujimura T; Terui T; Kusaka Y; Tagami H
    Br J Dermatol; 2004 Mar; 150(3):611-3. PubMed ID: 15030361
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1.
    Ullrich NJ; Zimmerman M; Smith E; Irons M; Marcus K; Kieran MW
    J Child Neurol; 2011 Feb; 26(2):228-30. PubMed ID: 20823033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moyamoya syndrome after radiation therapy for optic pathway glioma: case report.
    Serdaroğlu A; Simşek F; Gücüyener K; Oğuz A; Karadeniz C; Balibey M
    J Child Neurol; 2000 Nov; 15(11):765-7. PubMed ID: 11108514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Seizures in neurofibromatosis. What is the risk?].
    Drouet A
    Rev Neurol (Paris); 2011 Dec; 167(12):886-96. PubMed ID: 22041820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
    Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
    Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epilepsy surgery for a patient with neurofibromatosis type 1 concomitant with moyamoya syndrome.
    Kuroda N; Fujimoto A; Okanishi T; Sato K; Nishimura M; Enoki H
    J Clin Neurosci; 2019 Mar; 61():307-310. PubMed ID: 30381160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of Moyamoya syndrome and hemoglobin E/beta-thalassemia.
    Parker TM; Ward LM; Johnston DL; Ventureya E; Klaassen RJ
    Pediatr Blood Cancer; 2009 Mar; 52(3):422-4. PubMed ID: 19003908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant arteriovenous malformation associated with unilateral moyamoya disease in a child: case report.
    Chen Z; Zhu G; Feng H; Lin J; Wu N
    Surg Neurol; 2007 Jan; 67(1):89-92; discussion 93. PubMed ID: 17210313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperventilation-enhanced chorea as a transient ischaemic phenomenon in a patient with moyamoya disease.
    Spengos K; Tsivgoulis G; Toulas P; Vemmos K; Vassilopoulos D; Spengos M
    Eur Neurol; 2004; 51(3):172-5. PubMed ID: 15079090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.